Evidence map›Paper›PMID 9925643›Full record

ArticleGenes & development1999

ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system.

L P Ford, J Watson, J D Keene, J Wilusz

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 242 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. eLife · 2017
    Article
  11. Hallmarks of cancer and AU-rich elements.Wiley interdisciplinary reviews. RNA · 2017
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Coordinated post-transcriptional regulation of the chemokine system: messages from CCL2.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2014
    Review
  19. Review
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

L P FordDepartment of Microbiology and Molecular Genetics, University of Medicine and Dentistry of New Jersey (UMDNJ), New Jersey Medical School, Newark, New Jersey 07103, USA.
J Watson
J D Keene
J Wilusz
Rutgers, The State University of New Jersey · USDuke Medical Center · USRutgers New Jersey Medical School

Funding

MECHANISM OF 3 END FORMATION OF VIRAL PRE MRNASR01GM056434 · NIGMS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI WILUSZ, JEFFREY · 1997 to 2000
$261k
DETERMINANTS OF SPECIFICITY IN PROTEIN/RNA INTERACTIONSR01CA060083 · NCI · DUKE UNIVERSITY · PI KEENE, JACK D · 1993 to 1997
–
MOLECULAR AND IMMUNOPATHOLOGIC MECHANISMS OF CANCERT32CA009665 · NCI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI PONZIO, NICHOLAS M · 1994 to 1998
–
NCI NIH HHS CA09665NCI NIH HHS CA60083NCI NIH HHS T32 CA009665NIGMS NIH HHS GM56434
6 · The paper itself

Abstract

We have developed an in vitro mRNA stability system using HeLa cell cytoplasmic S100 extracts and exogenous polyadenylated RNA substrates that reproduces regulated aspects of mRNA decay. The addition of cold poly(A) competitor RNA activated both a sequence-specific deadenylase activity in the extracts as well as a potent, ATP-dependent ribonucleolytic activity. The rates of both deadenylation and degradation were up-regulated by the presence of a variety of AU-rich elements in the body of substrate RNAs. Competition analyses demonstrated that trans-acting factors were required for RNA destabilization by AU-rich elements. The approximately 30-kD ELAV protein HuR specifically bound to RNAs containing an AU-rich element derived from the TNF-alpha mRNA in the in vitro system. Interaction of HuR with AU-rich elements, however, was not associated with RNA destabilization. Interestingly, recombinant ELAV proteins specifically stabilized deadenylated intermediates generated from the turnover of AU-rich element-containing substrate RNAs. These data suggest that mammalian ELAV proteins play a role in regulating mRNA stability by influencing the access of degradative enzymes to RNA substrates.

Indexed as

Antigens, SurfaceRNA Processing, Post-TranscriptionalAdenosine TriphosphateBase SequenceBinding, CompetitiveCell ExtractsELAV-Like Protein 1ELAV ProteinsGenes, fosGenes, ViralGranulocyte-Macrophage Colony-Stimulating FactorHeLa CellsHumansKineticsMolecular WeightMutationAdenosine TriphosphateAntigens, SurfaceCell ExtractsELAVL1 protein, humanELAV-Like Protein 1ELAV ProteinsGranulocyte-Macrophage Colony-Stimulating FactorPoly ARecombinant ProteinsRibonucleoproteinsRNA-Binding ProteinsRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID9925643
PMCPMC316394
OpenAlexW2155146718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.